Human Genome Epidemiology Literature Finder
Records 1 - 9 (of 9 Records) |
Query Trace: Melanoma and ERBB2[original query] |
---|
Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway. Nature genetics 2015 Sep . Shain A Hunter, Garrido Maria, Botton Thomas, Talevich Eric, Yeh Iwei, Sanborn J Zachary, Chung Jongsuk, Wang Nicholas J, Kakavand Hojabr, Mann Graham J, Thompson John F, Wiesner Thomas, Roy Ritu, Olshen Adam B, Gagnon Alexander, Gray Joe W, Huh Nam, Hur Joe S, Busam Klaus J, Scolyer Richard A, Cho Raymond J, Murali Rajmohan, Bastian Boris |
Mutational dichotomy in desmoplastic malignant melanoma corroborated by multigene panel analysis. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2015 Jul 28 (7): 895-903. Jahn Stephan W, Kashofer Karl, Halbwedl Iris, Winter Gerlinde, El-Shabrawi-Caelen Laila, Mentzel Thomas, Hoefler Gerald, Liegl-Atzwanger Bernadet |
Rates of ERBB2 Alterations across Melanoma Subtypes and a Complete Response to Trastuzumab Emtansine in an ERBB2-Amplified Acral Melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 8 24 (23): 5815-5819. Gottesdiener Lee S, O'Connor Shannon, Busam Klaus J, Won Helen, Solit David B, Hyman David M, Shoushtari Alexander |
The identification of patient-specific mutations reveals dual pathway activation in most patients with melanoma and activated receptor tyrosine kinases in BRAF/NRAS wild-type melanomas. Cancer 2018 12 125 (4): 586-600. Appenzeller Silke, Gesierich Anja, Thiem Alexander, Hufnagel Anita, Jessen Christina, Kneitz Hermann, Regensburger Martina, Schmidt Cornelia, Zirkenbach Vanessa, Bischler Thorsten, Schilling Bastian, Siedel Claudia, Goebeler Maria-Elisabeth, Houben Roland, Schrama David, Gehrig Andrea, Rost Simone, Maurus Katja, Bargou Ralf, Rosenwald Andreas, Schartl Manfred, Goebeler Matthias, Meierjohann Sven |
Mutation profile of primary subungual melanomas in Caucasians. Oncotarget 2020 Jun 11 (25): 2404-2413. Borkowska Aneta, Szumera-Cieckiewicz Anna, Spalek Mateusz, Teterycz Pawel, Czarnecka Anna, Kowalik Artur, Rutkowski Pio |
Differences in Genomic Alterations Between Brain Metastases and Primary Tumors. Neurosurgery 2020 Dec . Dono Antonio, Takayasu Takeshi, Yan Yuanqing, Bundrant Bethany E, Arevalo Octavio, Lopez-Garcia Carlos A, Esquenazi Yoshua, Ballester Leomar |
Definition of Biologically Distinct Groups of Conjunctival Melanomas According to Etiological Factors and Implications for Precision Medicine. Cancers 2021 8 13 (15): . Gardrat Sophie, Houy Alexandre, Brooks Kelly, Cassoux Nathalie, Barnhill Raymond, Dayot Stéphane, Bièche Ivan, Raynal Virginie, Baulande Sylvain, Marais Richard, Roman-Roman Sergio, Stern Marc-Henri, Rodrigues Manu |
Germline ERBB2/HER2 Coding Variants Are Associated with Increased Risk of Myeloproliferative Neoplasms. Cancers 2021 7 13 (13): . Braunstein Evan M, Chen Hang, Juarez Felicia, Yang Fanghan, Tao Lindsay, Makhlin Igor, Williams Donna M, Chaturvedi Shruti, Pallavajjala Aparna, Karantanos Theodoros, Martin Renan, Wohler Elizabeth, Sobreira Nara, Gocke Christopher D, Moliterno Alison |
Actionable Mutation Profile of Sun-Protected Melanomas in South America. The American Journal of dermatopathology 2022 May . Hsieh Ricardo, Nico Marcello M S, Camillo Cláudia M C, Oliveira Kátia K, Carraro Dirce M, Sangueza Martin, Lourenço Silvia |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: